110 related articles for article (PubMed ID: 32579999)
1. Feasibility of patient specific quality assurance for proton therapy based on independent dose calculation and predicted outcomes.
Meijers A; Guterres Marmitt G; Ng Wei Siang K; van der Schaaf A; Knopf AC; Langendijk JA; Both S
Radiother Oncol; 2020 Sep; 150():136-141. PubMed ID: 32579999
[TBL] [Abstract][Full Text] [Related]
2. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
[TBL] [Abstract][Full Text] [Related]
3. Impact of machine log-files uncertainties on the quality assurance of proton pencil beam scanning treatment delivery.
Toscano S; Souris K; Gomà C; Barragán-Montero A; Puydupin S; Stappen FV; Janssens G; Matic A; Geets X; Sterpin E
Phys Med Biol; 2019 Apr; 64(9):095021. PubMed ID: 30897559
[TBL] [Abstract][Full Text] [Related]
4. Platform for automatic patient quality assurance via Monte Carlo simulations in proton therapy.
Guterres Marmitt G; Pin A; Ng Wei Siang K; Janssens G; Souris K; Cohilis M; Langendijk JA; Both S; Knopf A; Meijers A
Phys Med; 2020 Feb; 70():49-57. PubMed ID: 31968277
[TBL] [Abstract][Full Text] [Related]
5. Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation.
Handsfield LL; Jones R; Wilson DD; Siebers JV; Read PW; Chen Q
Med Phys; 2014 Oct; 41(10):101703. PubMed ID: 25281942
[TBL] [Abstract][Full Text] [Related]
6. Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans.
Kierkels RG; Korevaar EW; Steenbakkers RJ; Janssen T; van't Veld AA; Langendijk JA; Schilstra C; van der Schaaf A
Radiother Oncol; 2014 Sep; 112(3):430-6. PubMed ID: 25220369
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
8. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
9. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
[TBL] [Abstract][Full Text] [Related]
10. Novel Radiobiological Gamma Index for Evaluation of 3-Dimensional Predicted Dose Distribution.
Sumida I; Yamaguchi H; Kizaki H; Aboshi K; Tsujii M; Yoshikawa N; Yamada Y; Suzuki O; Seo Y; Isohashi F; Yoshioka Y; Ogawa K
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):779-86. PubMed ID: 25936816
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
12. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
13. On the new metrics for IMRT QA verification.
Garcia-Romero A; Hernandez-Vitoria A; Millan-Cebrian E; Alba-Escorihuela V; Serrano-Zabaleta S; Ortega-Pardina P
Med Phys; 2016 Nov; 43(11):6058. PubMed ID: 27806610
[TBL] [Abstract][Full Text] [Related]
14. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
[TBL] [Abstract][Full Text] [Related]
15. The dosimetric and radiobiological impact of calculation grid size on head and neck IMRT.
Srivastava SP; Cheng CW; Das IJ
Pract Radiat Oncol; 2017; 7(3):209-217. PubMed ID: 27847266
[TBL] [Abstract][Full Text] [Related]
16. Automation of routine elements for spot-scanning proton patient-specific quality assurance.
Hernandez Morales D; Shan J; Liu W; Augustine KE; Bues M; Davis MJ; Fatyga M; Johnson JE; Mundy DW; Shen J; Younkin JE; Stoker JB
Med Phys; 2019 Jan; 46(1):5-14. PubMed ID: 30339270
[TBL] [Abstract][Full Text] [Related]
17. Online adaptation and verification of VMAT.
Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
Med Phys; 2015 Jul; 42(7):3877-91. PubMed ID: 26133589
[TBL] [Abstract][Full Text] [Related]
18. Alternatives to patient specific verification measurements in proton therapy: a comparative experimental study with intentional errors.
Matter M; Nenoff L; Meier G; Weber DC; Lomax AJ; Albertini F
Phys Med Biol; 2018 Oct; 63(20):205014. PubMed ID: 30234498
[TBL] [Abstract][Full Text] [Related]
19. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.
Shan J; Sio TT; Liu C; Schild SE; Bues M; Liu W
Med Phys; 2019 Jan; 46(1):382-393. PubMed ID: 30387870
[TBL] [Abstract][Full Text] [Related]
20. The 3D isodose structure-based method for clinical dose distributions comparison in pretreatment patient-QA.
Tamborra P; Martinucci E; Massafra R; Bettiol M; Capomolla C; Zagari A; Didonna V
Med Phys; 2019 Feb; 46(2):426-436. PubMed ID: 30450559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
